In PREVENT‐Dementia, APOE4 carriers did not have a higher small vessel disease burden compared to non‐carriers (Low et al., 2022), however, in a subset of the ALFA study, the prevalence of WMH was higher in APOE4 homozygotes (Rojas et al., 2018). The gene discussed is APOE; the disease is dementia.